Pages that link to "Q34336210"
Jump to navigation
Jump to search
The following pages link to Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication (Q34336210):
Displaying 50 items.
- The hope for an HIV vaccine based on induction of CD8+ T lymphocytes--a review (Q24630490) (← links)
- Recombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8+ T-Cell Responses in Rhesus Macaques (Q27491052) (← links)
- HIV-1 Tat-based vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development. (Q30381447) (← links)
- Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review (Q30404393) (← links)
- Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity (Q31151209) (← links)
- Induction of long-lasting multi-specific CD8+ T cells by a four-component DNA-MVA/HIVA-RENTA candidate HIV-1 vaccine in rhesus macaques (Q33259057) (← links)
- SIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on isotypes, cytokines, and intracellular degradation (Q33636080) (← links)
- Timing of immune escape linked to success or failure of vaccination (Q33700493) (← links)
- Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection (Q33927681) (← links)
- Is an HIV vaccine possible? (Q33946263) (← links)
- Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys (Q33984182) (← links)
- Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239. (Q34226966) (← links)
- Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag (Q34228487) (← links)
- Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection (Q34348640) (← links)
- Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles (Q34465510) (← links)
- Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine. (Q34488930) (← links)
- Tat-neutralizing antibodies in vaccinated macaques (Q34755910) (← links)
- Antibodies, viruses and vaccines (Q34810301) (← links)
- AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogens (Q35024266) (← links)
- Will we be able to 'spot' an effective HIV-1 vaccine? (Q35053385) (← links)
- Effect on HIV-1 gene expression, Tat-Vpr interaction and cell apoptosis by natural variants of HIV-1 Tat exon 1 and Vpr from Northern India (Q35075250) (← links)
- Effects of MHC Class I on HIV/SIV Disease in Primates (Q35108712) (← links)
- T-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention (Q35613792) (← links)
- Not all cytokine-producing CD8+ T cells suppress simian immunodeficiency virus replication (Q35635247) (← links)
- Understanding the failure of CD8+ T-cell vaccination against simian/human immunodeficiency virus (Q35784787) (← links)
- Pirate primates in uncharted waters: lymphocyte transfers in unrelated, MHC-matched macaques (Q35874970) (← links)
- Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential? (Q35961192) (← links)
- Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection (Q36208138) (← links)
- HIV vaccine design: insights from live attenuated SIV vaccines (Q36343536) (← links)
- Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response (Q36399559) (← links)
- Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial (Q36402663) (← links)
- Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates (Q36510009) (← links)
- Vaccine protection by live, attenuated simian immunodeficiency virus in the absence of high-titer antibody responses and high-frequency cellular immune responses measurable in the periphery (Q36539997) (← links)
- Understanding the mechanisms and limitations of immune control of HIV. (Q36762540) (← links)
- Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection (Q36961218) (← links)
- Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans (Q36971813) (← links)
- Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection (Q37009569) (← links)
- What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? (Q37220038) (← links)
- Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge (Q37232824) (← links)
- Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques (Q37256687) (← links)
- Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection (Q37273289) (← links)
- DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge (Q37325709) (← links)
- Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization (Q37348901) (← links)
- Tonsillar application of AT-2 SIV affords partial protection against rectal challenge with SIVmac239. (Q37439455) (← links)
- Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine (Q39699309) (← links)
- Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses (Q39796603) (← links)
- Immunoprevalence of the CD4+ T-cell response to HIV Tat and Vpr proteins is provided by clustered and disperse epitopes, respectively (Q39933791) (← links)
- Sequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat protein (Q40273841) (← links)
- Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central Africa (Q40551477) (← links)
- A designed Tat immunogen generates enhanced anti-Tat C-terminal antibodies (Q43973641) (← links)